GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novomics Co Ltd (XKRX:283100) » Definitions » EV-to-EBITDA

Novomics Co (XKRX:283100) EV-to-EBITDA : -1.13 (As of Jun. 10, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Novomics Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Novomics Co's enterprise value is ₩2,523.0 Mil. Novomics Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-2,234.7 Mil. Therefore, Novomics Co's EV-to-EBITDA for today is -1.13.

The historical rank and industry rank for Novomics Co's EV-to-EBITDA or its related term are showing as below:

XKRX:283100' s EV-to-EBITDA Range Over the Past 10 Years
Min: -7.75   Med: -4.86   Max: -0.81
Current: -1.13

During the past 7 years, the highest EV-to-EBITDA of Novomics Co was -0.81. The lowest was -7.75. And the median was -4.86.

XKRX:283100's EV-to-EBITDA is ranked worse than
100% of 450 companies
in the Biotechnology industry
Industry Median: 9.385 vs XKRX:283100: -1.13

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-10), Novomics Co's stock price is ₩628.00. Novomics Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-821.000. Therefore, Novomics Co's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Novomics Co EV-to-EBITDA Historical Data

The historical data trend for Novomics Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novomics Co EV-to-EBITDA Chart

Novomics Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - - - - -8.08

Novomics Co Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA Get a 7-Day Free Trial - - - - -8.08

Competitive Comparison of Novomics Co's EV-to-EBITDA

For the Biotechnology subindustry, Novomics Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novomics Co's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novomics Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Novomics Co's EV-to-EBITDA falls into.



Novomics Co EV-to-EBITDA Calculation

Novomics Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2523.045/-2234.672
=-1.13

Novomics Co's current Enterprise Value is ₩2,523.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Novomics Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-2,234.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novomics Co  (XKRX:283100) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Novomics Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=628.00/-821.000
=At Loss

Novomics Co's share price for today is ₩628.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Novomics Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-821.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Novomics Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Novomics Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Novomics Co (XKRX:283100) Business Description

Traded in Other Exchanges
N/A
Address
171 Dangsan-ro, 304, 305, 306, 306-1, Yeongdeungpo-gu, Seoul, KOR
Novomics Co Ltd is a developer of a molecular diagnosis system for cancer treatment.

Novomics Co (XKRX:283100) Headlines

No Headlines